NCT04665973

Brief Summary

Despite significant evolution of cancer therapies from the early 20th century, these therapies are still associated with toxic effects that negatively impact the patient's performance status, quality of life and survival. The role of physical activity to counteract these side effects is acknowledged. However, cancer patients are often misinformed about the potential benefits of physical therapy during cancer therapy. In this context, the role of therapeutic patient education seems essential. Because of lack of time, therapeutic patient education (TPE) is often provided via an information booklet. However, the investigators assume that a face-to-face interview results in a greater impact on patient's behavior change (the level of physical activity during cancer therapy, in our case). This research project is designed to challenge this hypothesis. The investigators hypothesize that a brief oral educational session of 30 minutes provided at the very beginning of cancer therapy will enhance the physical activity level of our patients for at least 6 months, i.e. during their cancer therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

December 7, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 14, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2022

Completed
Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

1.6 years

First QC Date

December 7, 2020

Last Update Submit

April 16, 2024

Conditions

Keywords

Therapeutic Patient EducationPhysical Activity

Outcome Measures

Primary Outcomes (1)

  • Changes in PA level

    The PA level will be estimated in MET/h/week via the International Physical Activity Questionnaire (long form) validated in French in subjects aged 18-84 years. The questionnaire classifies the subject according to 3 activity levels: inactive, moderate, high

    At baseline and 6 months (at the occasion of a second follow-up visit set with the oncologist) after the start of the cancer therapy

Secondary Outcomes (8)

  • Changes in PA level

    At baseline and 3 months (at the occasion of a first follow-up visit set with the oncologist) after the start of the cancer therapy

  • Changes in BMI

    At baseline, 3 months and 6 months after the start of the cancer therapy

  • Changes in fatigue

    At baseline, 3 months and 6 months after the start of the cancer therapy

  • Changes in quality of life

    At baseline, 3 months and 6 months after the start of the cancer therapy

  • Changes in exercise capacity

    At baseline, 3 months and 6 months after the start of the cancer therapy

  • +3 more secondary outcomes

Study Arms (2)

Oral semi-structured interview

EXPERIMENTAL

The oral semi-structured interview uses the principles of motivational interviewing (partnership with the patient, no judgment, altruism, evocation) and follow the content of the booklet used in the control group.

Behavioral: Therapeutic patient education : oral semi-structured interview

Booklet

ACTIVE COMPARATOR

The information booklet was designed by the physiotherapists at Cliniques universitaires Saint-Luc and is specifically dedicated to raise patient's awareness about the benefits of physical activity (PA) in the context of cancer.

Behavioral: Therapeutic patient education : booklet (passive)

Interventions

The physiotherapist discusses and goes through each page of the booklet and involves the patient as much as possible. He demonstrates the exercises proposed in the booklet and then ask the patient to perform them in front of him. The physiotherapist tries to identify the patient's needs and suggests different ways to ensure that the patient has different opportunities to maintain the best possible level of PA

Oral semi-structured interview

The booklet (11 pages): explains why it is important to maintain a good level of PA as part of cancer treatment and reviews the most common side effects of cancer therapy and the relative importance of PA in combating these effects (pages 2-3) ; defines PA, its modalities and possible security precautions (pages 4-5), suggests exercises to be performed oneself and a target intensity to be reached (pages 6-8), provides a roadmap to be completed oneself (pages 9-10), and outlines procedures for joining an exercise medicine group (page 11).

Booklet

Eligibility Criteria

Age18 Years - 84 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged between 18 and 84 years
  • Suffering from a first cancer, with the exception of the following cancers in the patient's history (provided that they have been successfully treated):
  • non-melanoma skin cancer,
  • carcinoma in situ of the uterine cervix
  • ductal carcinoma in situ.
  • Preserved performance status (ECOG scale ≤ 1),
  • Starting one of the following systemic cancer therapies:
  • chemotherapy,
  • immunotherapy,
  • targeted therapies,
  • Able to understand and read French
  • Life expectancy of at least 1 year

You may not qualify if:

  • Poor cognitive function (Mini-Mental State Examination ≤ 24/30)
  • Having a recurrence of cancer, with the exception of the following cancers in the patient's history (provided that they have been successfully treated):
  • non-melanoma skin cancer,
  • carcinoma in situ of the uterine cervix,
  • ductal carcinoma in situ.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques universitaires Saint-Luc

Brussels, 1200, Belgium

Location

MeSH Terms

Conditions

NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 7, 2020

First Posted

December 14, 2020

Study Start

December 7, 2020

Primary Completion

July 29, 2022

Study Completion

July 29, 2022

Last Updated

April 17, 2024

Record last verified: 2024-04

Locations